Results 21 to 30 of about 8,115 (174)

Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation therapy (SBRT)

Frontiers in Oncology, 2016
: Purpose: To define prognostic factors associated with improved survival and local control for gynecologic cancer recurrences limited to the pelvis and para-aortic region using stereotactic body radiation therapy (SBRT).Methods: Between 2/2008 and 7 ...
Shaakir Hasan, Anthony Ricco, Kaylette Jenkins, Rachelle Lanciano, Alexandra Hanlon, John Lamond, Jun Yang, Jing Feng, Michael Good, Joel Noumoff, Luther Brady   +10 more
doaj   +1 more source

Salvage fractionated Stereotactic Radiotherapy (fSRT) with or without chemotherapy and immunotherapy for recurrent Glioblastoma Multiforme: A single institution experience

Frontiers in Oncology, 2015
Background: The current standard of care for salvage treatment of Glioblastoma Multiforme (GBM) is gross total resection and adjuvant chemoradiation for operable patients.
Shaakir eHasan, Eda eChen, Rachelle eLanciano, Rachelle eLanciano, Jun eYang, Jun eYang, Alex eHanlon, Alex eHanlon, John eLamond, John eLamond, Stephen eArrigo, Stephen eArrigo, William eDing, William eDing, Michael eMikhail, Arezoo eGhaneie, Luther eBrady, Luther eBrady   +17 more
doaj   +1 more source

The Comparison of Stereotactic Body Radiation Therapy (SBRT) andIntensity Modulated Radiation Therapy (IMRT) for prostate cancer byNCCN risk groups

Frontiers in Oncology, 2016
OBJECTIVES: The primary objective of this study is to compare freedom from biochemical failure (FFBF) between SBRT and IMRT for patients with organ confined prostate cancer treated between 2007 through 2012 utilizing the 2015 National Comprehensive ...
Anthony Ricco, Genevieve Manahan, Genevieve Manahan, Rachelle Lanciano, Rachelle Lanciano, Alexandra Hanlon, Jun Yang, Jun Yang, Stephen Arrigo, John Lamond, John Lamond, Jing Feng, Michael Mooreville, Bruce Garber, Luther Brady, Luther Brady   +15 more
doaj   +1 more source

CyberKnife S7 – radioterapia najwyższej precyzji [PDF]

, 2021
Od ponad 10 lat w Polsce pacjenci leczeni są robotem CyberKnife firmy Accuray. Pierwsza dostępna w naszym kraju wersja systemu, model VSI, zapoczątkowała erę cybernetycznej radiochirurgii stereotaktycznej. W 2012 roku pojawił się nowy model CyberKnife M6
Wocial, Przemysław
core  

Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis

Radiation Oncology, 2023
Background To investigate whether the rate of stereotactic body radiation therapy-related (SBRT-related) genitourinary (GU) toxicity is lower in patients with prostate cancer treated with CyberKnife.
Makoto Ito, Yasuo Yoshioka, Yuuki Takase, Junji Suzuki, Hironori Takahashi, Yoshitaka Minami, Ami Sakuragi, Yukihiko Oshima, Takahito Okuda, Kojiro Suzuki   +9 more
doaj   +1 more source

Influence of Specific Treatment Parameters on Nontarget and Out-of-Field Doses in a Phantom Model of Prostate SBRT with CyberKnife and TrueBeam

Life, 2022
The aim of the study was to determine the influence of a key treatment plan and beam parameters on overall dose distribution and on doses in organs laying in further distance from the target during prostate SBRT.
Marta Kruszyna-Mochalska, Agnieszka Skrobala, Piotr Romanski, Adam Ryczkowski, Wiktoria Suchorska, Katarzyna Kulcenty, Igor Piotrowski, Dorota Borowicz, Kinga Graczyk, Natalia Matuszak, Julian Malicki   +10 more
doaj   +1 more source

SBRT: An opportunity to improve quality of life for oligometastatic prostate cancer?

Frontiers in Oncology, 2015
Objective: Oligometastatic prostate cancer is a limited metastatic disease state in which potential long-term control is still possible with the use of targeted therapies such as surgery or stereotactic body radiation therapy (SBRT).
Gregory eAzzam, Rachelle eLanciano, Rachelle eLanciano, Steve eArrigo, Steve eArrigo, John eLamond, John eLamond, Billy eDing, Jun eYang, Jun eYang, Alexandra eHanlon, Michael eGood, Luther eBrady, Luther eBrady   +13 more
doaj   +1 more source

Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations

Advances in Radiation Oncology, 2020
Purpose: Lung reirradiation for nonsmall cell lung cancer (NSCLC) is common for either recurrent disease or new primary cancer. Dose volume tolerance of the lung after multiple courses of radiation therapy (RT) is unknown.
Anthony Ricco, MD, Sara Barlow, BS, Jing Feng, MS, Janson Jacob, MD, Alicia Lozano, MS, Alexandra Hanlon, PhD, Stephen Arrigo, MD, Olusola Obayomi-Davies, MD, John Lamond, MD, Jun Yang, PhD, Rachelle Lanciano, MD   +10 more
doaj   +1 more source

Treatment of Orbital Lesions using CyberKnife Stereotactic Radiosurgery [PDF]

, 2021
The purpose of the research done was to evaluate the use of CyberKnife Stereotactic Radiosurgery (SRS) for treating orbital lesions. Efficacy and tolerability of such treatment was analyzed with data drawn from multiple sources, regarding dose and ...
Morahan, Emily
core   +1 more source

Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report

Brain Sciences, 2022
(1) Background: Hypofractionated stereotactic radiotherapy (HSRT) and anti-vascular endothelial growth factor (VEGF) antibodies have been reported to have a promising survival benefit in recent studies.
Yun Guan, Jing Li, Xiu Gong, Huaguang Zhu, Chao Li, Guanghai Mei, Xiaoxia Liu, Li Pan, Jiazhong Dai, Yang Wang, Enmin Wang, Ying Liu, Xin Wang   +12 more
doaj   +1 more source